Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2012) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Natural Product Reports | journal | 3.623 Q1 | 211 | 72 | 242 | 10736 | 2497 | 233 | 9.99 | 149.11 |  |
| 2 | Critical Reviews in Toxicology | journal | 2.025 Q1 | 129 | 42 | 117 | 5856 | 849 | 112 | 7.27 | 139.43 | |
| 3 | Drugs in Context | journal | 36 | 3 | 0 | 310 | 0 | 0 | 0.00 | 103.33 | | |
| 4 | Expert Opinion on Emerging Drugs | journal | 0.898 Q2 | 54 | 44 | 137 | 4301 | 471 | 137 | 3.09 | 97.75 | |
| 5 | Expert Opinion on Drug Discovery | journal | 0.782 Q2 | 84 | 90 | 274 | 8586 | 627 | 273 | 2.42 | 95.40 | |
| 6 | Issues in Toxicology | book series | 0.195 Q3 | 18 | 72 | 68 | 6768 | 52 | 64 | 0.72 | 94.00 | |
| 7 | Expert Opinion on Drug Delivery | journal | 1.895 Q1 | 133 | 118 | 308 | 10235 | 1925 | 306 | 5.80 | 86.74 | |
| 8 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.942 Q2 | 100 | 127 | 366 | 10730 | 1396 | 363 | 3.62 | 84.49 | |
| 9 | Expert Opinion on Therapeutic Targets | journal | 1.788 Q1 | 106 | 138 | 337 | 11271 | 1536 | 335 | 4.36 | 81.67 | |
| 10 | Expert Opinion on Therapeutic Patents | journal | 1.330 Q1 | 88 | 100 | 339 | 7922 | 1229 | 333 | 3.47 | 79.22 | |
| 11 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.515 Q1 | 99 | 23 | 76 | 1791 | 447 | 75 | 4.75 | 77.87 | |
| 12 | Expert Opinion on Investigational Drugs | journal | 1.486 Q1 | 117 | 161 | 456 | 12444 | 2063 | 446 | 4.32 | 77.29 | |
| 13 | Neuropharmacology | journal | 2.315 Q1 | 191 | 408 | 798 | 31474 | 4103 | 782 | 4.39 | 77.14 | |
| 14 | Clinical Pharmacokinetics | journal | 2.254 Q1 | 184 | 56 | 179 | 4291 | 1219 | 160 | 7.01 | 76.63 | |
| 15 | Toxin Reviews | journal | 0.328 Q3 | 54 | 7 | 56 | 531 | 72 | 54 | 1.00 | 75.86 | |
| 16 | Future Medicinal Chemistry | journal | 1.047 Q1 | 90 | 191 | 426 | 13920 | 1083 | 338 | 2.58 | 72.88 | |
| 17 | BioDrugs | journal | 1.106 Q1 | 79 | 42 | 130 | 3053 | 546 | 127 | 3.62 | 72.69 | |
| 18 | Therapeutic Advances in Neurological Disorders | journal | 0.789 Q2 | 68 | 28 | 93 | 1970 | 302 | 89 | 4.05 | 70.36 | |
| 19 | Toxicology Research | journal | 47 | 23 | 0 | 1605 | 0 | 0 | 0.00 | 69.78 | | |
| 20 | Therapeutic Delivery | journal | 0.357 Q2 | 63 | 130 | 213 | 8982 | 223 | 202 | 1.05 | 69.09 | |
| 21 | Trends in Pharmacological Sciences | journal | 5.103 Q1 | 244 | 86 | 251 | 5885 | 2971 | 237 | 10.51 | 68.43 | |
| 22 | Molecular Diagnosis and Therapy | journal | 0.540 Q2 | 68 | 37 | 109 | 2509 | 237 | 102 | 1.88 | 67.81 | |
| 23 | EPMA Journal | journal | 0.208 Q3 | 52 | 13 | 107 | 879 | 106 | 96 | 0.99 | 67.62 | |
| 24 | Journal of Occupational Medicine and Toxicology | journal | 0.476 Q3 | 47 | 19 | 101 | 1232 | 168 | 100 | 1.74 | 64.84 | |
| 25 | Expert Opinion on Pharmacotherapy | journal | 0.756 Q2 | 93 | 251 | 812 | 16233 | 2240 | 780 | 2.71 | 64.67 | |
| 26 | Neuropsychopharmacology | journal | 4.716 Q1 | 249 | 282 | 758 | 18037 | 6223 | 723 | 8.26 | 63.96 | |
| 27 | Journal of Psychopharmacology | journal | 1.443 Q1 | 135 | 176 | 525 | 11248 | 1996 | 489 | 3.75 | 63.91 | |
| 28 | Expert Opinion on Biological Therapy | journal | 1.247 Q1 | 102 | 183 | 429 | 11683 | 1798 | 425 | 4.17 | 63.84 | |
| 29 | Journal of Drug Targeting | journal | 1.025 Q1 | 107 | 82 | 265 | 5121 | 887 | 258 | 3.39 | 62.45 | |
| 30 | Cardiovascular Therapeutics | journal | 1.009 Q2 | 54 | 74 | 153 | 4591 | 437 | 143 | 2.79 | 62.04 | |
| 31 | Drug Discovery Today: Disease Mechanisms | journal | 0.619 Q2 | 28 | 9 | 55 | 538 | 80 | 48 | 1.57 | 59.78 | |
| 32 | Drug Discovery Today | journal | 1.967 Q1 | 215 | 170 | 433 | 10127 | 2870 | 392 | 6.17 | 59.57 | |
| 33 | International Journal of Neuropsychopharmacology | journal | 2.131 Q1 | 125 | 127 | 377 | 7517 | 1865 | 359 | 4.78 | 59.19 | |
| 34 | F1000 Biology Reports | journal | 1.093 Q1 | 32 | 24 | 114 | 1414 | 248 | 113 | 2.18 | 58.92 | |
| 35 | Expert Review of Vaccines | journal | 1.331 Q1 | 105 | 150 | 465 | 8819 | 1801 | 378 | 3.92 | 58.79 | |
| 36 | Expert Review of Clinical Pharmacology | journal | 0.365 Q1 | 60 | 79 | 195 | 4432 | 237 | 171 | 1.38 | 56.10 | |
| 37 | Drug Discovery Today: Disease Models | journal | 0.228 Q3 | 33 | 33 | 65 | 1830 | 44 | 56 | 0.67 | 55.45 | |
| 38 | Particle and Fibre Toxicology | journal | 3.221 Q1 | 119 | 49 | 106 | 2648 | 1166 | 102 | 11.00 | 54.04 | |
| 39 | Biomarkers in Medicine | journal | 0.826 Q2 | 56 | 92 | 251 | 4922 | 597 | 209 | 2.71 | 53.50 | |
| 40 | Human Genomics | journal | 1.462 Q1 | 68 | 26 | 115 | 1348 | 396 | 99 | 2.71 | 51.85 | |
| 41 | Mutagenesis | journal | 1.353 Q1 | 102 | 88 | 242 | 4553 | 948 | 231 | 3.78 | 51.74 | |
| 42 | Journal of Applied Toxicology | journal | 0.810 Q2 | 103 | 106 | 274 | 5469 | 812 | 271 | 2.71 | 51.59 | |
| 43 | Tetrahedron | journal | 1.329 Q1 | 236 | 1255 | 3673 | 64433 | 11679 | 3649 | 3.10 | 51.34 | |
| 44 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 30 | 29 | 1504 | 63 | 29 | 2.36 | 50.13 | | |
| 45 | SAR and QSAR in Environmental Research | journal | 0.444 Q3 | 54 | 40 | 122 | 2004 | 234 | 121 | 1.77 | 50.10 | |
| 46 | Emerging Microbes and Infections | journal | 94 | 30 | 0 | 1498 | 0 | 0 | 0.00 | 49.93 | | |
| 47 | ChemMedChem | journal | 1.142 Q1 | 119 | 215 | 664 | 10563 | 2075 | 642 | 3.00 | 49.13 | |
| 48 | Drug Discovery Today: Technologies | journal | 0.593 Q2 | 62 | 39 | 59 | 1904 | 98 | 52 | 1.72 | 48.82 | |
| 49 | Clinical and Experimental Pharmacology and Physiology | journal | 0.779 Q2 | 115 | 153 | 550 | 7366 | 1221 | 508 | 2.22 | 48.14 | |
| 50 | Drug Discovery Today: Therapeutic Strategies | journal | 0.627 Q2 | 31 | 27 | 57 | 1299 | 59 | 49 | 0.71 | 48.11 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data